Hubei Guangji Pharmaceutical Co (SZSE:000952) LT-Debt-to-Total-Asset : 0.10 (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hubei Guangji Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.10.

Hubei Guangji Pharmaceutical Co's long-term debt to total assets ratio declined from Sep. 2023 (0.15) to Sep. 2024 (0.10). It may suggest that Hubei Guangji Pharmaceutical Co is progressively becoming less dependent on debt to grow their business.

Hubei Guangji Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Hubei Guangji Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.04

0.02

0.10

0.14

Hubei Guangji Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.15	0.14	0.13	0.08	0.10

Hubei Guangji Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Hubei Guangji Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	419.537	/	3029.517
	=	0.14

Hubei Guangji Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	319.536	/	3109.03
	=	0.10

Hubei Guangji Pharmaceutical Co (SZSE:000952) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hubei Guangji Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Guangji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030

Website

http://www.guangjipharm.com

Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.

Executives

Zou Guang Ming	Independent director
Guo Shao Zhi	Executives
Zhang Bin	Director
Guo Wen Chao	Supervisors
Sun Zhen Hua	Director
Liao Qing Jiang	Director
Wang Xin	Directors, executives
Hu Feng Lei	Supervisors
Ruan Zhong Yi	Executives
Zhang Ping	Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines